Compass 3: A Novel Transition Program to Reduce Disability After Stroke
Recruiting
N/A
Interventional Study
Stroke
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 55 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 520 (estimated)
- Sponsor
- Washington University School of Medicine · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study evaluates a program designed to help individuals transition from inpatient rehabilitation to home following an ischemic or hemorrhagic stroke. Half of the participants will receive a stroke education program while the other half will receive an environmental modifications program.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Aged ≥55 years at the time of screening
* Acute stroke diagnosis (IS or ICH) verified by the stroke team or medical record
* Independent in activities of daily living (ADLs) prior to stroke (premorbid Modified Rankin Scale score ≤2)
* Plan to discharge to home from an IR
* Cap…
Contacts